# Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients

> **NCT06648720** · NA · NOT_YET_RECRUITING · sponsor: **University Medical Center Ho Chi Minh City (UMC)** · enrollment: 3566 (estimated)

## Conditions studied

- Coronary Arterial Disease (CAD)
- Percutaneous Coronary Intervention (PCI)
- Intravascular Ultrasound
- Dual Antiplatelet Therapy

## Interventions

- **DRUG:** DAPT de-escalation

## Key facts

- **NCT ID:** NCT06648720
- **Lead sponsor:** University Medical Center Ho Chi Minh City (UMC)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 3566 (ESTIMATED)
- **Last updated:** 2024-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06648720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06648720, "Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06648720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*